Phase 2 Start~month

Phase 2 Start: A First-in-Human (FIH), Phase I/II, Multicenter, Open-Label Study to Evaluate the Safety, Tolerabili

Indication
Metastatic Triple-negative Breast Cancer; Triple-Negative Breast Cancer (TNBC); Advanced Triple-Negative Breast Cancer

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Start: A First-in-Human (FIH), Phase I/II, Multicenter, Open-Label Study to Evaluate the Safety, Tolerabili — TELO Phase 2 Start | BioSniper